Essex Bio-Technology (1061) Financial Statements

0 Followers

Essex Bio-Technology Financial Overview

Essex Bio-Technology's market cap is currently HK$1.93B. The company's EPS TTM is HK$0.273; its P/E ratio is 6.72; and it has a dividend yield of 3.37%. Essex Bio-Technology is scheduled to report earnings on March 23, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	HK$ 1.81B	HK$ 1.67B	HK$ 1.71B	HK$ 1.32B	HK$ 1.64B
Gross Profit	HK$ 1.62B	HK$ 1.50B	HK$ 1.54B	HK$ 1.19B	HK$ 1.40B
Operating Income	HK$ 410.48M	HK$ 320.72M	HK$ 310.33M	HK$ 272.97M	HK$ 403.15M
EBITDA	HK$ 410.48M	HK$ 400.71M	HK$ 418.38M	HK$ 313.54M	HK$ 436.65M
Net Income	HK$ 318.09M	HK$ 307.22M	HK$ 275.26M	HK$ 225.41M	HK$ 345.97M
Balance Sheet
Cash & Short-Term Investments	HK$ 784.14M	HK$ 560.74M	HK$ 515.03M	HK$ 543.49M	HK$ 671.35M
Total Assets	HK$ 3.49B	HK$ 2.98B	HK$ 2.83B	HK$ 2.71B	HK$ 2.86B
Total Debt	HK$ 346.90M	HK$ 187.04M	HK$ 294.02M	HK$ 489.73M	HK$ 565.19M
Net Debt	HK$ -435.83M	HK$ -370.13M	HK$ -215.82M	HK$ -53.75M	HK$ -106.15M
Total Liabilities	HK$ 1.08B	HK$ 859.33M	HK$ 903.78M	HK$ 981.03M	HK$ 1.13B
Stockholders' Equity	HK$ 2.41B	HK$ 2.12B	HK$ 1.92B	HK$ 1.73B	HK$ 1.73B
Cash Flow
Free Cash Flow	HK$ 131.71M	HK$ 324.07M	HK$ 211.16M	HK$ 99.87M	HK$ 164.63M
Operating Cash Flow	HK$ 306.32M	HK$ 368.47M	HK$ 339.21M	HK$ 382.79M	HK$ 409.16M
Investing Cash Flow	HK$ -165.17M	HK$ -106.59M	HK$ -54.34M	HK$ -302.03M	HK$ -280.08M
Financing Cash Flow	HK$ 62.10M	HK$ -200.81M	HK$ -309.92M	HK$ -169.11M	HK$ -73.13M

Currency in HKD

Essex Bio-Technology Earnings and Revenue History

Income Statement >

Essex Bio-Technology Debt to Assets

Balance Sheet >

Essex Bio-Technology Cash Flow

Cash Flow >

Essex Bio-Technology Forecast EPS vs Actual EPS

Earnings >